PATENT CLAIM ANALYSIS

Application Number: 15910525
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
Modified viruses and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including cancer, and as anti-tumor and/or antiangiogenic agents. The viruses also can be used in diagnostic methods.

Claim (Index 3):
The method of  claim 1 , wherein the recombinant vaccinia virus comprises replacement of the A34R gene with the A34R gene from vaccinia IHD-J strain.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.63889
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14638604', '13136519', '11975090', '12080766', '12660314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.729311132810315
- 35 USC 102 Novelty (BERT): 0.6171069910293198
- Combined Prediction Score: 0.7180907186322154
- Mean Citation Score: 511.316062
- Max Citation Score: 563.9477
- Similarity Product: 500.2652880735994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test